Citi Investment Research

Analysts at Citi Research initiated coverage on Costco Wholesale Corporation (NASDAQ: COST) with a Buy rating and $150 price target Monday. Oliver Chen highlighted factors that may yield upside in shares of Costco: Costco provides high-end products for affordable prices. Costco offers a low...

In a report published Friday, Citi Investment Research analyst Terence Whalen upgraded International Rectifier (NYSE: IRF) from Neutral to Buy and assigned a $33.00 price target. International Rectifier reported revenue of $269.9 million versus Citi's $268 million estimate. Management announced...

In a report published Friday, Citi Investment Research analyst Terence Whalen analyzed specialty semiconductors and noted solid industrial exposure and limited smartphone exposure driving growth in 2014 for Linear Technology (NASDAQ: LLTC). Whalen upgraded Linear Technology from Neutral to Buy and...

Citi Investment Research is out with a research report on Dell (NASDAQ: DELL) and it is reiterating its Buy rating and $20 price target on shares. In a note to clients, Citi Investment Research writes, "3FQ revs came in ~2% light, however, EPS of $0.54 were above the street's $0.47 primarily due...

Citi Investment Research is out with a research report on Urban Outfitters Inc. (NASDAQ: URBN) and it is reiterating its Buy rating and a $34 price target on shares after it reported earnings. In a note to clients, Citi Investment Research writes, "Inventory ended 3Q higher than we expected as the...

Citi Investment Research is out with a research report on McDermott International Inc (NYSE: MDR) and it is lowering its price target to $15 from $22.50, but is keeping its Buy rating on shares. In a note to clients, Citi Investment Research writes, "MDR shared a preliminary 2012 outlook, which...

Citi Investment Research is out with a research report on Amgen (NASDAQ: AMGN) and it has a Buy rating and a $65 price target on shares. In a note to clients, Citi Investment Research writes, "─Our analysis of weekly IMS scrips suggests that US Prolia sales are tracking at $47.6M vs. Citi Q4 ests...

Citi Investment Research is out with a research report on Home Depot (NYSE: HD) and it has a Buy rating and a $44 price target on shares. In a note to clients, Citi Investment Research writes, "We rate HD as a Buy as we see a clear organic runway through market share gains while maintaining...

Citi Investment Research is out with a research report on Dick's Sporting Goods Inc (NYSE: DKS) and it has a Buy rating and a $43 price target on shares. In a note to clients, Citi Investment Research writes, "We remain constructive on the name based on 1) guidance for flat comps in 2H which...

Citi Investment Research is out with a research report on Staples Inc (NASDAQ: SPLS) and it has a Neutral rating and a $15 price target on shares. In a note to clients, Citi Investment Research writes, "We remain on the sidelines for SPLS. We see limited upside from current levels on 1) OM%...

Citi Investment Research is out with a research report on salesforce.com (NYSE: CRM) and it is raising its price target to $122 from $158, and is upgrading shares from Buy to Neutral. In a note to clients, Citi Investment Research writes, "Our change in opinion is based on increasing confidence in...

Citi Investment Research is out with a research report on Alimera Sciences Inc (NASDAQ: ALIM) and it is downgrading shares to Neutral and it has a $12 price target. In a note to clients, Citi Investment Research writes, "We are downgrading ALIM to Neutral (from Buy) as the FDA indicated on Friday...

Citi Investment Research is out with a research report on Johnson & Johnson Inc (NYSE: JNJ) and it has a Buy rating and a $72 price target on shares. In a note to clients, Citi Investment Research writes, "The ATLAS data backed the 9/30 preliminary release that the primary endpoint was met,...

Citi Investment Research is out with a research report on KKR & Co. (NYSE: KKR) and it has a Buy rating and a $17 price target on shares. In a note to clients, Citi Investment Research writes, "Maintain Buy; $17 SOTP price target following CIRA-sponsored investor meetings with senior...

Citi Investment Research is out with a research report on Catalyst Health Solutions, Inc. (NASDAQ: CHSI) and it is lowering its price target to $63 from $74, and it has a Buy rating on shares. In a note to clients, Citi Investment Research writes, "CHSI shares have sold off about 15% since the...